Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S9 from Venetoclax Induces BCL-2–Dependent Treg to TH17 Plasticity to Enhance the Antitumor Efficacy of Anti–PD-1 Checkpoint Blockade
  1. Home
  2. Publications
  3. Figure S9 from Venetoclax Induces BCL-2–Dependent Treg to TH17 Plasticity to Enhance the Antitumor Efficacy of Anti–PD-1 Checkpoint Blockade

Figure S9 from Venetoclax Induces BCL-2–Dependent Treg to TH17 Plasticity to Enhance the Antitumor Efficacy of Anti–PD-1 Checkpoint Blockade

Authors:
  • RLRosy Liao
    Rosy Liao
  • JHJocelyn Y. Hsu
    Jocelyn Y. Hsu
  • Nada S. Aboelella
    Nada S. Aboelella
  • JMJoshua A. McKeever
    Joshua A. McKeever
  • ATAnika T. Thomas-Toth
    Anika T. Thomas-Toth
  • AKAndrew S. Koh
    Andrew S. Koh
  • JLJames L. LaBelle
    James L. LaBelle

Open Access
Publisher website
Google Scholar
  • 17 June 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2326-6066.32703256
Abstract
Supplementary Figure S9. Tamoxifen does not alter T cell subpopulation cells or MC38 growth
Keywords
  • VENETOCLAX INDUCES
  • DEPENDENT TREG
  • CHECKPOINT BLOCKADE
  • ANTITUMOR EFFICACY
  • BLOCKADE SUPPLEMENTARY
  • SUPPLEMENTARY FIGURE
  • FIGURE
  • INDUCES
  • DEPENDENT
  • PLASTICITY
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.